PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: laura.pala@ieo.it.\', \'Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.\', \'Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haematology, University of Milan, Milan, Italy.\', \'Department of Pharmacy, European Institute of Oncology IRCCS, Milan, Italy.\', \'Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0093-7754(20)30087-710.1053/j.seminoncol.2020.07.010
?:doi
?:hasPublicationType
?:journal
  • Seminars in oncology
is ?:pmid of
?:pmid
?:pmid
  • 32883537
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.099
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32883537>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32883537>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all